Pyxis Oncology Successfully Completes Acquisition of Apexigen
Go back to Pyxis Oncology Successfully Completes Acquisition of Apexigen| (NASDAQ: PYXS) | Delayed: 2.91 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.91 | 52 Week High | $ | |||
| Open | $2.90 | 52 Week Low | $ | |||
| Day High | $3.05 | P/E | N/A | |||
| Day Low | $2.74 | EPS | $ | |||
| Volume | 1,724,820 | |||||
